Fig. 1From: Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinomaIn-field recurrence free rate at 1-yr and 2-yrs were 85.3Â % (76.2-91.1) and 81.6Â % (71.2-88.6), respectively. Out-field recurrence free rate at 1-yr and 2-yrs were 51.5Â % (41.2-60.8) and 49.5Â % (38.9-59.2), respectivelyBack to article page